Transcriptomics

Dataset Information

0

Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information


ABSTRACT: In patients with metastatic melanoma, the identification and validation of accurate prognostic biomarkers will assist rational treatment planning. Studies based on "-omics" technologies have focussed on a single high-throughput data type such as gene or microRNA transcripts. Occasionally, these features were evaluated in conjunction with limited clinico-pathologic data. With the increased availability of multiple data types, there is a pressing need to tease apart which of these sources contain the most valuable prognostic information. We evaluated and integrated several data types derived from the same tumor specimens in AJCC stage III melanoma patients - gene, protein, and microRNA expression as well as clinical, pathologic and mutation information - to determine their relative impact on prognosis. We used classification frameworks based on pre-validation and bootstrap multiple imputation classification to compare the prognostic power of each data source, both individually as well as integratively. We found that the prognostic utility of clinico-pathologic information was not out-performed by various "-omics" platforms. Rather, a combination of clinico-pathologic variables and mRNA expression data performed best. Furthermore, a patient-based classification analysis revealed that the prognostic accuracy of various data types was not the same for different patients, providing useful insights for ongoing developments in the individualized treatment of melanomas patients. SPECIAL NOTE: In this study, survival data were re-extracted from the MIA research database for all patients and brought up to date, revealing discrepancies affecting survival class in the case of four patients compared with the previous dataset (GSE53118: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53118). The current survival data are considered to be more accurate although the expression information has not changed. In addition, there were 5 samples (122, 144, 195, 264, and 358) for which gene expression information were not available at the time of analysis. However, the associated clinical information for these samples is provided since it was analysed elsewhere in the accompanying publication.

ORGANISM(S): Homo sapiens

PROVIDER: GSE54467 | GEO | 2014/08/18

SECONDARY ACCESSION(S): PRJNA236747

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2014-08-18 | E-GEOD-54467 | biostudies-arrayexpress
2012-04-01 | E-MTAB-1007 | biostudies-arrayexpress
2012-09-18 | E-GEOD-40954 | biostudies-arrayexpress
2012-09-18 | GSE40954 | GEO
2015-01-21 | E-GEOD-48073 | biostudies-arrayexpress
2019-10-29 | GSE127985 | GEO
2014-03-07 | E-GEOD-53622 | biostudies-arrayexpress
2014-03-07 | E-GEOD-53624 | biostudies-arrayexpress
2010-07-30 | E-GEOD-18018 | biostudies-arrayexpress
| PRJNA236747 | ENA